GE HealthCare Technologies Inc. (GEHC)
Unveiling GE HealthCare (GEHC) Q3 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for GE HealthCare (GEHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
What You Need To Know Ahead of GE HealthCare's Earnings
GE HealthCare (GEHC) is set to report earnings Wednesday morning, with analysts projecting revenue and profits to rise from the same time last year.
GEHC Stock Declines Despite the Unveiling of CareIntellect Application
GE Healthcare announces CareIntellect for Oncology to provide multi-modal patient data from disparate systems into a single view using generative AI.
GE HealthCare announces time-saving AI tool for doctors who treat cancer
GE HealthCare announced a new artificial intelligence application it said will save time for doctors who diagnose and treat cancer. The tool, called CareIntellect for Oncology, can quickly summarize patients' histories, monitor disease progression and identify relevant clinical trials, the company said.
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business
GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
GEHC's continued focus on innovations, acquisitions and partnerships raise optimism about the stock.
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.
US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery disease, the company said on Friday.
GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch
GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.
GE HealthCare: The Image Of More Upside Is Very Real
GE HealthCare Technologies has shown promising performance, with a 12% stock increase since June, outperforming the S&P 500's 2.9% rise. Despite some revenue declines in key segments, the PDx segment's 12.5% growth and overall profitability improvements are encouraging. Management's revised guidance suggests a positive outlook, with expected EPS growth and improved EBIT margins, indicating strong future potential.
